Cas:58077-34-2 N-benzyl-N’-phenylethane-1,2-diamine manufacturer & supplier

Chemical Name:N-benzyl-N’-phenylethane-1,2-diamine

CAS.NO:58077-34-2

Synonyms:N-Benzyl-N’-phenyl-aethylendiamin;N-benzyl-N’-phenyl-ethylenediamine;N-phenyl-N’-phenylmethyl-1,2-ethanediamine;N-phenyl-N’-benzylethylenediamine

Molecular Formula:C₁₅H₁₈N₂

Molecular Weight:226.31700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:24.06000

Exact Mass:226.14700

LogP:3.35220

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Benzyl-N’-phenyl-aethylendiamin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-phenyl-N’-benzylethylenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-phenyl-N’-phenylmethyl-1,2-ethanediamine Use and application,N-Benzyl-N’-phenyl-aethylendiamin technical grade,usp/ep/jp grade.

Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. N-benzyl-N’-phenylethane-1,2-diamine manufacturer A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. N-benzyl-N’-phenylethane-1,2-diamine supplier Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. N-benzyl-N’-phenylethane-1,2-diamine vendor Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. N-benzyl-N’-phenylethane-1,2-diamine factory Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.